期刊文献+

行与未行HAART的艾滋病病人的死亡原因分析 被引量:15

An analysis of the causes of death among AIDS patients before and after HAART and relevant nursing care
原文传递
导出
摘要 目的分析进行和未进行高效抗反转录病毒治疗(HAART)的艾滋病(AIDS)病人的死亡原因,探索护理对策。方法回顾性分析1996-2009年北京地坛医院住院治疗的AIDS死亡病例的临床资料,并对进行和未进行HAART者的死亡原因、免疫状态和病程等进行比较分析。结果 1996-2009年共有66例AIDS病人住院治疗,未行HAART的48例病人的死亡原因为:44例(91.6%)死于艾滋病相关机会性感染,2例(4.2%)死于消耗综合征和非艾滋病相关性疾病,其中1例(2.1%)为失血性休克;18例行HAART的病人中,死于艾滋病相关机会性感染7例(38.9%),死于乳酸酸中毒、慢性重型肝炎所致的肝衰竭各3例(16.7%),死于消化道出血所致的失血性休克2例(11.1%),死于消耗综合征、脑梗死、极重度贫血/粒细胞缺乏症各1例(5.5%)。结论 HAART治疗后,AIDS病人临床相发生了明显变化,在临床实践中应注意观察并采取相应措施。在治疗过程中的护理,要提高病人服药依从性,并注意监测抗病毒药物的不良反应,做到早发现、早治疗。 Objective To analyze the causes of death among AIDS patients before and after HAART and explore relevant nursing care.Methods The clinical data of 68 dead AIDS patients who had been hospitalized in Beijing Ditan Hospital from 1996 to 2009 were retrospectively analyzed,which included HAART,opportunistic infection,immunity and the causes of death.The courses of disease progression were compared between the patients receiving HAART and those without HAART.Results A total of 66 patients were hospitalized in the hospital in 1996-2009.The causes of death of the patients who did not receive HAART were opportunistic infection(46 cases,95.8%),wasting syndrome(2 cases,4.2%) and hemorrhagic shock(1 case,3.4%),while the causes of death of those who received HAART were :AIDS associated opportunistic infection(7 cases,38.9%),wasting syndrome(1 case,5.6%),lactic acidosis(3 cases,16.7%) and liver failure due to severe hepatitis(3 cases,16.7%).Conclusions The clinical manifestations of AIDS have changed significantly after HAART,close observation and proper management should be provided to the patients,and meticulous nursing care is essential to improve patients' compliance and monitor possible adverse reactions of ARV drugs.
出处 《中国艾滋病性病》 CAS 2010年第5期467-469,共3页 Chinese Journal of Aids & STD
关键词 艾滋病 死亡原因 机会性感染 乳酸酸中毒 护理对策 AIDS Causes of death Opportunistic infection Lactic acidosis Nursing care
  • 相关文献

参考文献6

二级参考文献11

  • 1徐小元.HCV、HIV混合感染的研究[J].临床肝胆病杂志,2004,20(4):220-222. 被引量:18
  • 2周伟,危剑安,孙利民,黄霞珍,陈宇霞,宋春鑫.AIDS的高效抗逆转录病毒疗法的毒副作用[J].中国艾滋病性病,2005,11(1):73-75. 被引量:31
  • 3王爱霞.艾滋病[J].中华内科杂志,1996,35(10):715-717. 被引量:6
  • 4王爱霞.艾滋病病因治疗的进展[J].中华传染病杂志,1997,15(1):1-2. 被引量:11
  • 5刘德纯,林清森.艾滋病相关卡波西肉瘤32例尸检材料病理学研究[J].蚌埠医学院学报,1997,22(3):146-148. 被引量:8
  • 6Rowland-Jones SL Timeline: AIDS pathogenesis What have two decades of HIV research taught us? [J]. Nat Rev Immunology, 2003,3(4):343-348. 被引量:1
  • 7Lewden C, Salmon D, Morlat P, et al. Cause of death among human immunodeficiency virus (HIV)-infected adults in the era of protect an-tiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS[J]. Int Epidemiology, 2004,12(23):1521-1530. 被引量:1
  • 8Montaner JS, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial,Italy,The Netherlands, Canada and Australia Study[J]. JAMA,1998,279(12):930-937. 被引量:1
  • 9Eron JJ Jr,Murphy RL, Petersan D, et al. A comparison of stavudine didanosine and indinarvir with zidovudine lamivudine and indinavir for the initial treatment of HIV-1 infected individuals selection of thymi-dine anolog regemen therapy[J]. AIDS,2000,14(11 ):1601-1610. 被引量:1
  • 10Moore RD, Keruly JC, Chaisson RE. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs[J]. AIDS,2001,15(5):617-620. 被引量:1

共引文献66

同被引文献157

引证文献15

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部